Should I buy or sell InMode stock right now?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for InMode in the last twelve months. There are currently 4 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" INMD shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in INMD, but not buy additional shares or sell existing shares. View INMD analyst ratings or view top-rated stocks .

What is InMode's stock price target for 2024?

6 brokerages have issued 12-month price objectives for InMode's shares. Their INMD share price targets range from $22.00 to $61.00. On average, they predict the company's share price to reach $32.80 in the next twelve months. This suggests a possible upside of 85.4% from the stock's current price. View analysts price targets for INMD or view top-rated stocks among Wall Street analysts .

How have INMD shares performed in 2024?

InMode's stock was trading at $22.24 at the beginning of 2024. Since then, INMD stock has decreased by 20.5% and is now trading at $17.69. View the best growth stocks for 2024 here .

When is InMode's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 2nd 2024. View our INMD earnings forecast .

How can I listen to InMode's earnings call?

InMode will be holding an earnings conference call on Thursday, May 2nd at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at 412-317-0088 with passcode "9531570".

How were InMode's earnings last quarter?

InMode Ltd. (NASDAQ:INMD) posted its quarterly earnings data on Tuesday, February, 13th. The healthcare company reported $0.71 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.66 by $0.05. The healthcare company earned $126.80 million during the quarter, compared to analysts' expectations of $124.77 million. InMode had a net margin of 40.22% and a trailing twelve-month return on equity of 29.80%. The company's revenue for the quarter was down 5.1% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.69 earnings per share.

What ETFs hold InMode's stock?

ETFs with the largest weight of InMode (NASDAQ:INMD) stock in their portfolio include iShares MSCI Israel ETF (EIS) , ARK Israel Innovative Technology ETF (IZRL) and Amplify BlueStar Israel Technology ETF (ITEQ) . VanEck Israel ETF (ISRA) .

When did InMode's stock split?

Shares of InMode split on the morning of Thursday, September 30th 2021. The 2-1 split was announced on Friday, September 17th 2021. The newly created shares were payable to shareholders after the closing bell on Monday, September 27th 2021. An investor that had 100 shares of stock prior to the split would have 200 shares after the split.

What guidance has InMode issued on next quarter's earnings?

InMode updated its FY 2024 earnings guidance on Tuesday, April, 9th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $485.0 million-$495.0 million, compared to the consensus revenue estimate of $498.8 million.

What is Moshe Mizrahy's approval rating as InMode's CEO?

1 employees have rated InMode Chief Executive Officer Moshe Mizrahy on Glassdoor.com . Moshe Mizrahy has an approval rating of 100% among the company's employees. This puts Moshe Mizrahy in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of InMode own?

Based on aggregate information from My MarketBeat watchlists, some companies that other InMode investors own include NVIDIA (NVDA) , Alibaba Group (BABA) , Salesforce (CRM) , Micron Technology (MU) , AbbVie (ABBV) , Advanced Micro Devices (AMD) , Block (SQ) , Tesla (TSLA) , DocuSign (DOCU) and PayPal (PYPL) .

InMode (INMD) raised $75 million in an initial public offering (IPO) on Thursday, August 8th 2019. The company issued 5,000,000 shares at a price of $14.00-$16.00 per share. Barclays, UBS Investment Bank and Canaccord Genuity acted as the underwriters for the IPO and Baird was co-manager.

Who are InMode's major shareholders?

InMode's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include IMC Chicago LLC (0.00%).

How do I buy shares of InMode?

Shares of INMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

Does InMode have any subsidiaries?

The following companies are subsidiares of InMode: Guangzhou InMode Medical Technology Ltd., InMode Asia Limited., InMode India Private Limited, InMode Japan KK, InMode M.D. Ltd., Invasix Corp., Invasix Iberia S.L., Invasix Inc., and Invasix UK Ltd.. Read More

NASDAQ:INMD

InMode (INMD) Stock Price, News & Analysis

→ Elon Musk’s ChatGPT Could Soon Mint New Millionaires (From InvestorPlace) (Ad)

Free INMD Stock Alerts

$17.69

-0.23 (-1.28%)

(As of 04/15/2024 ET)

Compare

Today's Range: $17.40
▼
$18.07
50-Day Range: $17.69
▼
$26.49
52-Week Range: $17.40
▼
$48.25

Volume: 2.20 million shs
Average Volume: 1.61 million shs
Market Capitalization: $1.49 billion

P/E Ratio: 7.69
Dividend Yield: N/A
Price Target: $32.80

Get InMode alerts:

InMode MarketRank™ Stock Analysis

Analyst Rating: Hold
2.33 Rating Score
Upside/Downside: 85.4% Upside
$32.80 Price Target
Short Interest: Healthy
7.04% of Shares Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 0.12
Based on 39 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: 7.84%
From $2.04 to $2.20 Per Share

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.11 out of 5 stars

Medical Sector

345th out of 929 stocks

Electromedical Equipment Industry

6th out of 18 stocks

3.2

Analyst's Opinion

Consensus Rating
InMode has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on 2 buy ratings, 4 hold ratings, and no sell ratings.
Amount of Analyst Coverage
InMode has only been the subject of 3 research reports in the past 90 days.

3.0

Short Interest

Percentage of Shares Shorted
7.04% of the outstanding shares of InMode have been sold short.
Short Interest Ratio / Days to Cover
InMode has a short interest ratio ("days to cover") of 3.7, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in InMode has recently decreased by 2.96%, indicating that investor sentiment is improving.

0.0

Dividend Strength

Dividend Yield
InMode does not currently pay a dividend.
Dividend Growth
InMode does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for INMD.

2.3

News and Social Media Coverage

News Sentiment
InMode has a news sentiment score of 0.12. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.66 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 39 news articles for InMode this week, compared to 7 articles on an average week.
Search Interest
32 people have searched for INMD on MarketBeat in the last 30 days. This is an increase of 78% compared to the previous 30 days.
MarketBeat Follows
Only 2 people have added InMode to their MarketBeat watchlist in the last 30 days. This is a decrease of -82% compared to the previous 30 days.

1.7

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, InMode insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 6.92% of the stock of InMode is held by insiders.
Percentage Held by Institutions
68.04% of the stock of InMode is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

2.5

Earnings and Valuation

Earnings Growth
Earnings for InMode are expected to grow by 7.84% in the coming year, from $2.04 to $2.20 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of InMode is 7.69, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 142.33.
Price to Earnings Ratio vs. Sector
The P/E ratio of InMode is 7.69, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 249.28.
Price to Book Value per Share Ratio
InMode has a P/B Ratio of 2.65. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad InvestorPlace

“Forget Tesla, this is Elon’s Next Big Thing”

According to Forbes, this breakthrough could define the future of AI. Most people don’t know about it… Because it was found 750 miles away from Silicon Valley.

Click here to see the details.

About InMode Stock (NASDAQ:INMD)

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel.

INMD Stock Price History

30 days | 90 days | 365 days | Advanced Chart

INMD Stock News Headlines

April 16, 2024 | americanbankingnews.com

InMode (NASDAQ:INMD) Sets New 1-Year Low on Analyst Downgrade

April 15, 2024 | markets.businessinsider.com

FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of InMode

April 16, 2024 | InvestorPlace (Ad)

“Forget Tesla, this is Elon’s Next Big Thing”

According to Forbes, this breakthrough could define the future of AI. Most people don’t know about it… Because it was found 750 miles away from Silicon Valley.

April 15, 2024 | prnewswire.com

INMD DEADLINE TODAY: ROSEN, LEADING TRIAL ATTORNEYS, Encourages InMode Ltd. Investors to Secure Counsel Before Important April 15 Deadline in Securities Class Action - INMD

April 15, 2024 | stockhouse.com

FINAL INMD DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds InMode Ltd. Investors to Join the Class Action Lawsuit!

April 15, 2024 | prnewswire.com

Shareholders of InMode Ltd. Should Contact Levi & Korsinsky Before April 15, 2024 to Discuss Your Rights - INMD

April 15, 2024 | prnewswire.com

FINAL DEADLINE TODAY: The Schall Law Firm Encourages Investors in InMode Ltd. with Losses of $500,000 to Contact the Firm

April 14, 2024 | americanbankingnews.com

Barclays Lowers InMode (NASDAQ:INMD) Price Target to $33.00

April 16, 2024 | InvestorPlace (Ad)

REVEALED: Elon Musk’s Secret A.I. Facility?

I recently shot this video outside what could be Elon Musk’s biggest secret. What’s happening inside these walls is so important that our government has declared it a matter of national security.

April 13, 2024 | nasdaq.com

RSI Alert: InMode (INMD) Now Oversold

April 13, 2024 | prnewswire.com

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of InMode

April 12, 2024 | msn.com

3 Best Stocks to Buy Now, 4/12/2024, According to Top Analysts

April 12, 2024 | prnewswire.com

INMD Investors Have Opportunity to Lead InMode Ltd. Securities Fraud Lawsuit

April 12, 2024 | prnewswire.com

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against InMode Ltd.- INMD

April 12, 2024 | prnewswire.com

Shareholders that lost money on InMode Ltd.(INMD) should contact The Gross Law Firm about pending Class Action - INMD

April 11, 2024 | stockhouse.com

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against InMode Ltd. (INMD)

April 11, 2024 | msn.com

3 Reasons I'd Consider Selling InMode’s Unusually Active Put Option

April 11, 2024 | businesswire.com

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against InMode Ltd.

April 11, 2024 | stockhouse.com

4-DAY DEADLINE ALERT: The Schall Law Firm Encourages Investors in InMode Ltd. with Losses of $500,000 to Contact the Firm

April 11, 2024 | americanbankingnews.com

InMode (NASDAQ:INMD) Sets New 52-Week Low at $18.20

April 10, 2024 | prnewswire.com

InMode Ltd. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - INMD

April 10, 2024 | americanbankingnews.com

InMode (NASDAQ:INMD) Receives Hold Rating from Needham & Company LLC

April 10, 2024 | americanbankingnews.com

InMode Target of Unusually High Options Trading (NASDAQ:INMD)

April 9, 2024 | stockhouse.com

INVESTOR DEADLINE MONDAY: InMode Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - INMD

April 9, 2024 | msn.com

InMode slips after guidance cut

April 9, 2024 | prnewswire.com

InMode to Report First Quarter 2024 Financial Results and Hold Conference Call May 2, 2024

April 9, 2024 | prnewswire.com

Investors in InMode Ltd. Should Contact The Gross Law Firm Before April 15, 2024 to Discuss Your Rights - INMD

See More Headlines

Receive INMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for InMode and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 2/13/2024
Today: 4/15/2024
Next Earnings (Confirmed): 5/02/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Electromedical equipment
Sub-Industry: N/A
Current Symbol: NASDAQ:INMD
CUSIP: N/A
CIK: 885988
Web: www.inmodemd.com
Phone: 972-4909-7470
Fax: N/A
Employees: 581
Year Founded: 2008

Price Target and Rating

Average Stock Price Target: $32.80
High Stock Price Target: $61.00
Low Stock Price Target: $22.00
Potential Upside/Downside: +85.4%
Consensus Rating: Hold
Rating Score (0-4): 2.33
Research Coverage: 6 Analysts

Profitability

EPS (Most Recent Fiscal Year): $2.30
Trailing P/E Ratio: 7.69
Forward P/E Ratio: 8.67
P/E Growth: N/A
Net Income: $197.92 million
Net Margins: 40.22%
Pretax Margin: 44.30%
Return on Equity: 29.80%
Return on Assets: 27.02%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 12.51
Quick Ratio: 11.87

Sales & Book Value

Annual Sales: $492.05 million
Price / Sales: 3.02
Cash Flow: $2.18 per share
Price / Cash Flow: 8.10
Book Value: $6.68 per share
Price / Book: 2.65

Miscellaneous

Outstanding Shares: 83,980,000
Free Float: 78,170,000
Market Cap: $1.49 billion
Optionable: Optionable
Beta: 2.16

Social Links

Beginners Guide To Retirement Stocks

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Key Executives

Mr. Yair Malca (Age 46)
Chief Financial Officer
Comp: $581k
Ms. Nava Tal-Launer
Chief Information Officer
Mr. Shakil Lakhani (Age 41)
President of North America
Comp: $3.49M
Mr. Moshe Mizrahy (Age 71)
Chairman & CEO
Comp: $216k
Mr. Alon Yaari
Vice President of Operations
Dr. Michael Kreindel (Age 56)
CTO & Director
Comp: $221k
Dr. Spero Theodorou M.D. (Age 52)
Chief Medical Officer
Comp: $1.84M

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions

INMD Stock Analysis - Frequently Asked Questions

Should I buy or sell InMode stock right now?: 6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for InMode in the last twelve months. There are currently 4 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" INMD shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in INMD, but not buy additional shares or sell existing shares.
View INMD analyst ratings or view top-rated stocks.
What is InMode's stock price target for 2024?: 6 brokerages have issued 12-month price objectives for InMode's shares. Their INMD share price targets range from $22.00 to $61.00. On average, they predict the company's share price to reach $32.80 in the next twelve months. This suggests a possible upside of 85.4% from the stock's current price.
View analysts price targets for INMD or view top-rated stocks among Wall Street analysts.
How have INMD shares performed in 2024?: InMode's stock was trading at $22.24 at the beginning of 2024. Since then, INMD stock has decreased by 20.5% and is now trading at $17.69.
View the best growth stocks for 2024 here.
When is InMode's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, May 2nd 2024.
View our INMD earnings forecast.
How can I listen to InMode's earnings call?: InMode will be holding an earnings conference call on Thursday, May 2nd at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at 412-317-0088 with passcode "9531570".
How were InMode's earnings last quarter?: InMode Ltd. (NASDAQ:INMD) posted its quarterly earnings data on Tuesday, February, 13th. The healthcare company reported $0.71 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.66 by $0.05. The healthcare company earned $126.80 million during the quarter, compared to analysts' expectations of $124.77 million. InMode had a net margin of 40.22% and a trailing twelve-month return on equity of 29.80%. The company's revenue for the quarter was down 5.1% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.69 earnings per share.
What ETFs hold InMode's stock?: ETFs with the largest weight of InMode (NASDAQ:INMD) stock in their portfolio include iShares MSCI Israel ETF (EIS), ARK Israel Innovative Technology ETF (IZRL) and Amplify BlueStar Israel Technology ETF (ITEQ).VanEck Israel ETF (ISRA).
When did InMode's stock split?: Shares of InMode split on the morning of Thursday, September 30th 2021. The 2-1 split was announced on Friday, September 17th 2021. The newly created shares were payable to shareholders after the closing bell on Monday, September 27th 2021. An investor that had 100 shares of stock prior to the split would have 200 shares after the split.

What guidance has InMode issued on next quarter's earnings?: InMode updated its FY 2024 earnings guidance on Tuesday, April, 9th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $485.0 million-$495.0 million, compared to the consensus revenue estimate of $498.8 million.
What is Moshe Mizrahy's approval rating as InMode's CEO?: 1 employees have rated InMode Chief Executive Officer Moshe Mizrahy on Glassdoor.com. Moshe Mizrahy has an approval rating of 100% among the company's employees. This puts Moshe Mizrahy in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.
What other stocks do shareholders of InMode own?: Based on aggregate information from My MarketBeat watchlists, some companies that other InMode investors own include NVIDIA (NVDA), Alibaba Group (BABA), Salesforce (CRM), Micron Technology (MU), AbbVie (ABBV), Advanced Micro Devices (AMD), Block (SQ), Tesla (TSLA), DocuSign (DOCU) and PayPal (PYPL).
When did InMode IPO?: InMode (INMD) raised $75 million in an initial public offering (IPO) on Thursday, August 8th 2019. The company issued 5,000,000 shares at a price of $14.00-$16.00 per share. Barclays, UBS Investment Bank and Canaccord Genuity acted as the underwriters for the IPO and Baird was co-manager.
Who are InMode's major shareholders?: InMode's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include IMC Chicago LLC (0.00%).
How do I buy shares of InMode?: Shares of INMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.
Does InMode have any subsidiaries?: The following companies are subsidiares of InMode: Guangzhou InMode Medical Technology Ltd., InMode Asia Limited., InMode India Private Limited, InMode Japan KK, InMode M.D. Ltd., Invasix Corp., Invasix Iberia S.L., Invasix Inc., and Invasix UK Ltd..
Read More

This page (NASDAQ:INMD) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

InMode (INMD) Stock Price, News & Analysis

InMode MarketRank™ Stock Analysis

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

News Sentiment

News Coverage This Week

Search Interest

MarketBeat Follows

Company Ownership

Earnings and Valuation

About InMode Stock (NASDAQ:INMD)

INMD Stock Price History

INMD Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Social Links

Key Executives

Key Competitors

Institutional Ownership

INMD Stock Analysis - Frequently Asked Questions

Overall MarketRank^™